ArticleHemaSphere

Higher Adherence to Treatment With Low-Molecular-Weight-Heparin Nadroparin Than Enoxaparin Because of Side Effects in Cancer-Associated Venous Thromboembolism.

Sake J van der Wall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.